Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: Analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice

International Immunology

Volumn 10, Issue 12, 1998, Pages 1765-1776

  Boyton, Rosemary J ^a   Lohmann, Tobias ^b   Londei, Marco ^c   Kalbacher, Hubert ^d   Halder, Thomas ^d   Frater, Arlene J ^a   Douek, Daniel C ^a   Leslie, R David G ^e   Flavell, Richard A ^f   Altmann, Daniel M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glutamic acid decarboxylase; HLA DQ; Non obese diabetic mouse; Transgenic mouse; Type I diabetes

Indexed keywords

GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MONOZYGOTIC TWINS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENE;

EID: 7844239774     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.12.1765     Document Type: Article

References (48)

1. Lohmann, T., Leslie, R. D., Hawa, M., Geysen, M., Rodda, S. and Londei, M. 1994. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 343:1607.
2. Atkinson, M. A., Bowman, M. A., Campbell, L., Darrow, B. L., Kaufman, D. L. and Maclaren, N. K. 1994. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 94:2125.
3. Kaufman, D. L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G. S., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J. and Lehmann, P. V. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
4. Tisch, R., Yang, X. D., Singer, S. M., Liblau, R. S., Fugger, L. and McDevitt, H. O. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72.
5. Wicker, L. S., Todd, J. A. and Peterson, L. B. 1995. Genetic control of diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179.
6. Lund, T. O'Reilly, L., Hutchings, P., Kanagawa, O, Simpson, E., Gravely. R., Chandler, P., Dyson, J., Picard, J. K., Edwards, A., et al. 1990. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature 345:727.
7. Hanson, M. S., Cetkovic-Cvrlje, M., Ramiya, V. K., Atkinson, M. A., Maclaren, N. K., Singh, B., Elliott, J. F., Serreze, D. V. and Leiter, E. H. 1996. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection J. Immunol. 157:1279.
8. + nonobese diabetic mice develop insulitis and diabetes. J. Exp. Med. 178:793.
9. Deng, H., Apple, R., Clare-Salzler, M., Trembleau, S., Mathis, D., Adorini, L. and Sercarz. E. 1993. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J. Exp. Med. 178:1675.
10. Tun, R. Y., Peakman, M., Alviggi, L., Hussain, MJ, Lo, S. S., Shattock, M., Pyke, D. A., Bottazzo, G. F., Vergani, D. and Leslie, R. D. 1994. Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins. Br. Med. J. 308:1063.
11. Todd, J. A., Bell, J. I. and McDevitt, H. O. 1987. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599.
12. Caillat-Zucman, S., Garchon, H. J., Timsit, J., Assan, R., Boitard, C., Djilali-Saiah, I., Bougneres, P. and Bach, J. F. 1992. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J. Clin. Invest. 90:2242.
13. Kwok, W. W., Domeier, M. E., Johnson, M. L., Nepom, G. T and Koelle, D. M. 1996. HLA-DQB1 codon 57 is critical for peptide binding and recognition. J. Exp. Med. 183:1253.
14. Wucherpfennig, K. W. and Strominger, J. L 1995. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181:1597.
15. Valli, A., Sette, A., Kappos, L., Oseroff, C., Sidney, J., Miescher, G., Hochberger, M., Albert, E. D. and L. Adorini. 1993. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J. Clin. Invest. 91:616.
16. Hammer, J., Bono, E., Gallazzi, F., Belunis, C., Nagy, Z. and Sinigaglia. F. 1994. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J. Exp. Med. 180:2353.
17. Fairchild, P. J., Wildgoose, R., Atherton, E., Webb, S. and Wraith, D. C. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5:1151.
18. Phelps, R. G., Turner, A. N. and Rees, A. J. 1996. Direct identification of naturally processed autoantigen-derived peptides bound to HLA-DR15. J. Biol. Chem. 271:18549.
19. LIU, G. Y., Fairchild, P. J., Smith, R. M., Prowle. J. R., Kioussis, D. and Wraith D. C. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407.
20. Muraro, P. A., Vergelli, M., Kalbus, M., Banks, D, E., Nagle, J. W., Tranquill, L. R., Nepom, G. T., Biddison, W. E., McFarland, H. E. and Martin, R. 1997. Immunodominance of a low-affinity major histocompatability complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. J. Clin. Invest. 100:339.
21. g7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156:450.
22. g7 protein of non-obese diabetic mice. Eur. J. Immunol. 27:2478.
23. Reece, J C., Geysen, H. M. and Rodda, S. J. 1993. Mapping the major human T helper epitopes of tetanus toxin. The emerging picture. J. Immunol. 151:6175.
24. Lohmann, T., Leslie, R. D. G. and Londei, M. 1996 T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J Autoimmun. 9:385.
25. Kropshofer, H., Max, H., Muller, C. A., Hesse, F., Stevanovic, S., Jung, G. and Kalbacher, H. 1992. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif. J. Exp. Med. 175:1799.
26. Max, H., Halder, T., Kalbus, M., Gnau, V, Jung. G. and Kalbacher, H. 1994. A 16mer peptide of the human autoantigen calreticulin is a most prominent HLA-DR4Dw4-associated self-peptide. Hum. Immunol. 41:39.
27. Picard J. K. 1993. Single-step allele-specific polymerase chain reaction HLA-DQ genotyping using ARMS primers. Hum. Immunol. 38:115.
28. Altmann, D. M., Sattentau, Q. J., Trowsdale, J. and Beverley, P. C. L. 1989. Modulation of HLA class II expression following infection by HIV. In Dupont, B., ed., Immunobiology of HLA, vol. II, p. 352. Springer-Verlag, New York.
29. Ota, K., Matsui, M., Milford, E. L., Mackin, G. A., Weiner, H. L. and Hafler, D. A. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183.
30. Kwok, W, W., Domeier, M. L., Raymond, F. C., Byers, P. and Nepom, G. T. 1996. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156:2171.
31. + single transgenic mice. J. Immunol. 146:854.
32. Altmann, D. M., Douek, D. C., Frater, A. J., Hetherington, C. M., Inoko, H. and Elliot, J 1995. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J. Exp. Med. 181:867.
33. g7 in non-obese diabetic mice, Immunogenetics 46:29.
34. Utz, U., Biddison, W. E., McFarland, H. F., McFarlin, D. E., Flerlage, M. and Martin, R. 1993. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature 364:243.
35. Shanmugam, A., Copie-Bergman, C., Falissard, B., Delrieu, O., Jais, J. P., Rebibo, D., Bach J. F. and Tournier-Lasserve, E. 1996. TCR alpha beta gene usage for myelin basic protein recognition in healthy monozygous twins. J. Immunol. 156:3747.
36. Altmann D. M., Sansom, D. and Marsh, S. G. 1991. What is the basis for HLA-DQ associations with autoimmune disease? Immunol. Today 12, 8:267.
37. Shirai M., Arichi, T., Nishioka, M., Nomura, T., Ikeda, K., Kawanishi, K., Engelhard, V. H. Feinstone, S. M. and Berzofsky, J. A. 1995. CTL responses of HLA-A2.1 transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2. 1. J. Immunol. 154:2733.
38. Man S., Newberg, M. H., Crotzer, V. L., Luckey, C. J., Williams, N. S., Chen, Y., Huczko, E. L., Ridge, J. P. and Engelhard, V. J. 1995. Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2. 1 transgenic mice. Int. Immunol. 7:597.
39. Nabozny, G. H., Baisch, J. M., Cheng, S., Cosgrove, D., Griffiths, M. M., Luthra H. S and David, C. S. 1996. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183:27.
40. Elliott, J. I., and Altmann, D. M. 1995. Dual T cell receptor alpha chain T cells in autoimmunity. J. Exp. Med. 182:953.
41. Birk, O. S., Douek, D. C., Elias, D., Takacs, K., Dewchand, H., . Gur, S. L, Walker, M. D., van der Zee, R., Cohen, I. R. and Altmann, D. M. 1996. A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc. Natl Acad. Sci. USA 93:1032.
42. Campbell, I. L., Kay, T. W., Oxbrow, L. and Harrison, L. C. 1991, Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87:739.
43. Debray Sachs, M., Carnaud, C., Boitard, C., Cohen, H., Gresser, I., Bedossa, P. and Bach, J. F. 1991. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J. Autoimmun. 4:237.
44. Hultgren, B., Huang, X., Dybdal, N and Stewart, T. A. 1996. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45:812.
45. h2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1561.
46. Windhagen, A., Anderson, D. E., Carrizosa, A., Williams, R. E. and Hafler, D. A. 1996. IL-12 induces human T cells secreting IL-10 with IFN-gamma. J. Immunol. 157:1127.
47. h1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-gamma or IL-2 determines their function. Int. Immunol. 7:1287.
48. Lee, M. S., Mueller, R., Wicker, L. S., Peterson, L. B and Sarvetnick, N. 1996. IL- 10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183:2663.